We are currently expanding our manufacturing footprint with a new facility in Puntland, Somalia, which will double our production capacity.
We also plan to open new regional offices in South Sudan and Ethiopia.
Strategic collaborations with global pharmaceutical brands will allow us to introduce biosimilars and advanced therapies in African markets.
We are also exploring digital health solutions, including e-pharmacy platforms and AIpowered supply chain systems to improve last-mile delivery efficiency.